Formulation comprising buprenorphine
Details for Australian Patent Application No. 2003216842 (hide)
International Classifications
Event Publications
31 July 2003 Complete Application Filed
Priority application(s): 0225040.5 28.10.02 GB; 0206448.3 19.03.02 GB; 0225041.3 28.10.02 GB; 0225042.1 28.10.02 GB
13 November 2003 Application Open to Public Inspection
Published as AU-B-2003216842
30 November 2006 Assignment before Grant
Ionix Pharmaceuticals Limited; West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited The application has been assigned to Ionix Pharmaceuticals Limited; Archimedes Development Limited
13 December 2007 Application Accepted
Published as AU-B-2003216842
10 April 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003216843-DIRECTLY MODULATED LASER DIODE WITH CHIRP CONTROL
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser